Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.31 |
| ▸ | ST6GAL1 | P15907 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.30 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.30 |
| ▸ | GRIA1 | P42261 | 3/20 | 0.30 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25382857 | 1.00 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL25385302 | 1.00 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL5535320 | 0.93 | APP (0.42) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL16370305 | 0.91 | APP (0.41) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL11784499 | 0.91 | APP (0.41) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL5026578 | 0.84 | — | — | |
| SCHEMBL918218 | 0.83 | APP (0.35) | APPALDH1A1TSHRGRIA1EPHX2 | |
| SCHEMBL329052 | 0.82 | APP (0.46) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL1924621 | 0.82 | ALDH1A1 (0.33) | TP53ALDH1A1MAPTTDP1TSHR | |
| SCHEMBL11551439 | 0.82 | PTGS1 (0.38) | APPPTGS1PDE4ALMNASLC6A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5147454-A | Bath comprising mixture of alkanesulfonic acids or alkanolsulfonic acids, a tin salt thhereof, a lead salt thereof, a thiourea derivative and a mono-, di-, or tricarboxylic acid or salt thereof | OKUNO CHEMICAL INDUSTRIES CO., LTD. (JP) | 1992-09-15 | — | — | US | claimed |
| US-12509789-B2 | Sulfonate electroplating bath, process for refining metal by electrolytic depositing and process for controlling metal morphology in electrolytic refining | BASF SE (DE) | 2025-12-30 | — | — | US | disclosed |
| US-20240287696-A1 | SULFONATE ELECTROPLATING BATH, PROCESS FOR REFINING METAL BY ELECTROLYTIC DEPOSITING AND PROCESS FOR CONTROLLING METAL MORPHOLOGY IN ELECTROLYTIC REFINING | BASF ADVANCED CHEMICALS CO., LTD. (CN) | 2024-08-29 | — | — | US | disclosed |
| EP-4341468-A1 | SULFONATE ELECTROPLATING BATH, PROCESS FOR REFINING METAL BY ELECTROLYTIC DEPOSITING AND PROCESS FOR CONTROLLING METAL MORPHOLOGY IN ELECTROLYTIC REFINING | BASF SE (DE) | 2024-03-27 | — | — | EP | disclosed |
| CN-117321252-A | Sulfonate plating bath, method of refining metal by electrowinning and method of controlling metal morphology in electrorefining | 巴斯夫欧洲公司 | 2023-12-29 | — | — | CN | disclosed |
| US-20230270751-A1 | BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION | PFIZER INC. | 2023-08-31 | — | — | US | disclosed |
| WO-2022243145-A1 | SULFONATE ELECTROPLATING BATH, PROCESS FOR REFINING METAL BY ELECTROLYTIC DEPOSITING AND PROCESS FOR CONTROLLING METAL MORPHOLOGY IN ELECTROLYTIC REFINING | BASF SE (DE) | 2022-11-24 | — | — | WO | disclosed |
| CN-112601527-A | Selective anticancer agents for effective prophylaxis and treatment | 分子国际研究公司 | 2021-04-02 | — | — | CN | disclosed |
| US-20170209345-A1 | DENTAL PROSTHESIS | MITSUI CHEMICALS, INC. (JP) | 2017-07-27 | — | — | US | disclosed |
| US-RE45310-E1 | Cathode active material, cathode therewith and nonaqueous electrolyte secondary battery | SONY CORPORATION (JP) | 2014-12-30 | — | — | US | disclosed |
| US-5554211-A | IMIDAZOLE-2-THIONE COMPLEXING AGENT | MCGEAN-ROHCO, INC. (US) | 1996-09-10 | — | — | US | disclosed |
| US-5302256-A | Organic sulfonic acid, tin and lead salts thereof, and thiourea; low temperature, high speed | LEARONAL JAPAN INC. (JP) | 1994-04-12 | — | — | US | disclosed |
| EP-0520421-A2 | Immersion tin/lead alloy plating bath | LEARONAL JAPAN Inc. (JP) | 1992-12-30 | — | — | EP | disclosed |
| US-5147454-A | Bath comprising mixture of alkanesulfonic acids or alkanolsulfonic acids, a tin salt thhereof, a lead salt thereof, a thiourea derivative and a mono-, di-, or tricarboxylic acid or salt thereof | OKUNO CHEMICAL INDUSTRIES CO., LTD. (JP) | 1992-09-15 | — | — | US | disclosed |
| EP-0196232-B1 | PLATING BATH AND METHOD FOR ELECTROPLATING TIN AND/OR LEAD | MCGEAN-ROHCO, INC. (US) | 1991-11-21 | — | — | EP | disclosed |
| US-4885064-A | SOLUBLE TIN, LEAD OR ALLOY SALT AND APHA-ACETYLINIC ALCOHOL OR GLYCOL; SMOOTH, LEVEL, MATTE OR BRIGHT | MCGEAN-ROHCO, INC. (US) | 1989-12-05 | — | — | US | disclosed |
| US-4662999-A | Plating bath and method for electroplating tin and/or lead | MCGEAN-ROHCO, INC. (US) | 1987-05-05 | — | — | US | disclosed |
| EP-0196232-A2 | Plating bath and method for electroplating tin and/or lead | MCGEAN-ROHCO, INC. (US) | 1986-10-01 | — | — | EP | disclosed |
| US-4582576-A | LEAD OR TIN SALT A SULFONIC ACID, SURFACTANT, AND BRIGHTENERS | MCGEAN-ROHCO, INC. (US) | 1986-04-15 | — | — | US | disclosed |
| US-3959362-A | Ammonium mercaptoalkanesulfonate salts, their preparation, photographic fixing solutions containing same, and method of fixing photographic film therewith | EASTMAN KODAK COMPANY (US) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270751-A1 | BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION | CNR1, CNR2, SIGMAR1 | APP 3911/4885PTGS1 2431/4885PDE4A 4791/4885 |
| US-20170209345-A1 | DENTAL PROSTHESIS | CAD, OR10J3, PSMA3 | APP 2519/4885PTGS1 3561/4885PDE4A 2511/4885 |
| US-12509789-B2 | Sulfonate electroplating bath, process for refining metal by electrolytic depositing and process for controlling metal morphology in electrolytic refining | SCNN1G, SCNN1B, SCNN1A | APP 2328/4885PTGS1 3243/4885PDE4A 4344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.